Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | CCR5 | P51681 | 1/20 | 0.37 |
| ▸ | HTR2C | P28335 | 1/20 | 0.35 |
| ▸ | HTR6 | P50406 | 1/20 | 0.34 |
| ▸ | HTR3A | P46098 | 1/20 | 0.32 |
| ▸ | SLC6A1 | P30531 | 3/20 | 0.31 |
| ▸ | SLC6A11 | P48066 | 2/20 | 0.31 |
| ▸ | SLC6A13 | Q9NSD5 | 2/20 | 0.31 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | PNMT | P11086 | 1/20 | 0.30 |
| ▸ | APLNR | P35414 | 2/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
| ▸ | NOS2 | P35228 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8017282 | 1.00 | ALDH1A1 (0.47) | ALDH1A1CCR5HTR2CHTR6HTR3A | |
| SCHEMBL1037842 | 1.00 | ALDH1A1 (0.47) | ALDH1A1CCR5HTR2CHTR6HTR3A | |
| SCHEMBL14620877 | 1.00 | ALDH1A1 (0.47) | ALDH1A1CCR5HTR2CHTR6HTR3A | |
| SCHEMBL6426932 | 1.00 | ALDH1A1 (0.47) | ALDH1A1CCR5HTR2CHTR6HTR3A | |
| SCHEMBL165540 | 1.00 | ALDH1A1 (0.47) | ALDH1A1CCR5HTR2CHTR6HTR3A | |
| SCHEMBL24912524 | 1.00 | ALDH1A1 (0.47) | ALDH1A1CCR5HTR2CHTR6HTR3A | |
| SCHEMBL14772 | 1.00 | ALDH1A1 (0.47) | ALDH1A1CCR5HTR2CHTR6HTR3A | |
| SCHEMBL1037843 | 1.00 | ALDH1A1 (0.47) | ALDH1A1CCR5HTR2CHTR6HTR3A | |
| SCHEMBL22540086 | 1.00 | ALDH1A1 (0.47) | ALDH1A1CCR5HTR2CHTR6HTR3A | |
| SCHEMBL12440357 | 1.00 | ALDH1A1 (0.47) | ALDH1A1CCR5HTR2CHTR6HTR3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230348524-A1 | TECHNOLOGIES FOR OLIGONUCLEOTIDE PREPARATION | WAVE LIFE SCIENCES LTD. (SG) | 2023-11-02 | — | — | US | disclosed |
| CN-101622242-B | Bicyclic derivatives as CETP inhibitors | NOVARTIS AG | 2013-07-17 | — | — | CN | disclosed |
| CN-101622242-A | Bicyclic derivatives as CETP inhibitors | NOVARTIS AG | 2010-01-06 | — | — | CN | disclosed |
| CN-101389606-A | Pyridinyl amine derivatives as inhibitors of cholesteryl ester transfer protein (CETP) | NOVARTIS AG (CH) | 2009-03-18 | — | — | CN | disclosed |
| US-7465751-B2 | 1-substituted-3-pyrrolidine derivatives as muscarinic receptor antagonists | RANBAXY LABORATORIES LIMITED (IN) | 2008-12-16 | — | — | US | disclosed |
| US-20060194862-A1 | 1-Substituted-3-pyrrolidine derivatives as muscarinic receptor antagonists | RANBAXY LABORATORIES LIMITED (IN) | 2006-08-31 | — | — | US | disclosed |
| EP-1583741-A1 | 1-SUBSTITUTED-3-PYRROLIDINE DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS | Ranbaxy Laboratories, Limited (IN) | 2005-10-12 | — | — | EP | disclosed |
| WO-2004056767-A1 | 1-SUBSTITUTED-3-PYRROLIDINE DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS | RANBAXY LABORATORIES LIMITED (IN) | 2004-07-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060194862-A1 | 1-Substituted-3-pyrrolidine derivatives as muscarinic receptor antagonists | CHRM3, CHRM1, CHRM5 | ALDH1A1 821/4885CCR5 191/4885HTR2C 264/4885 |
| US-20230348524-A1 | TECHNOLOGIES FOR OLIGONUCLEOTIDE PREPARATION | POLRMT, DCLRE1B, RNGTT | ALDH1A1 3318/4885CCR5 323/4885HTR2C 4505/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.